Scientific Datafrom Clinical Trials: Investigators' Responsibilities and Rights
暂无分享,去创建一个
J. Cameron | A. Cuschieri | J. Neoptolemos | C. Balch | R. Rutherford | W. Souba | V. Fazio | D. Mcfadden | K. Johnston | W. Pories | H. Polk | A. Warshaw | M. Sarr | K. Kelly | C. Scott-Conner | L. Rikkers | J. Grosfeld | B. Macfadyen | J. Murie | S. Schwartz | T. Bowden | M. Buechler | B. A. Pruitt | Maurice E Arrequi | Ronald K Thompkins
[1] R. Rutherford,et al. Protecting the rights of investigators in industry-supported clinical research. , 2002, Journal of vascular surgery.
[2] J. Kahn,et al. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial. , 2000, JAMA.
[3] R. Rutherford,et al. Potential problems with industry-supported clinical research. , 2000, Journal of Vascular Surgery.
[4] D. Rennie. Fair conduct and fair reporting of clinical trials. , 1999, JAMA.
[5] Melissa S. Anderson,et al. Withholding research results in academic life science. Evidence from a national survey of faculty. , 1997, JAMA.